Genmab reported 4.64 in EPS Earnings Per Share for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Agios Pharmaceuticals AGIO:US -1.44 28.39
Alexion Pharmaceuticals ALXN:US $ 3.52 0.56
Almirall ALM:SM 0.08 0.16
Amarin AMRN:US $ 0.02 0.02
Amgen AMGN:US $ 4.38 0.68
Argen X Bv ARGX:BB 1.98 2.65
AstraZeneca AZN:LN 0.9 0.73
Bayer BAYN:GR € 1.61 0.98
Biomarin Pharmaceutical BMRN:US $ 0.07 0.02
Bluebird Bio BLUE:US $ -3.43 0.36
Exelixis EXEL:US 0.3 0.3
Fresenius Medical Care FME:GR € 0.76 0.09
Galapagos GLPG:NA € -0.98 1.12
Genmab GEN:DC 4.64 11.97
GlaxoSmithKline GSK:LN 0.28 0.05
GN Store Nord GN:DC DK 3.25 0.36
GRIFOLS GRF:SM € 0.24 0.07
H. Lundbeck A/S LUN:DC 1.9 1.23
Hikma Pharmaceutical HIK:LN 0.96 0.1
Immunogen IMGN:US -0.15 0.02
Insmed INSM:US -0.91 0.02
Lonza Group LONN:SW 6.97 2.22
Merck MRK:GR € 2.24 0.06
Novartis NOVN:VX SF 1.66 0.14
Regeneron Pharmaceuticals REGN:US $ 25.8 15.91
Sanofi SAN:FP € 1.38 0.23
Seattle Genetics SGEN:US $ -0.47 0.2
UCB UCB:BB 2.92 1.07
William Demant Holding WDH:DC 4.94 0.76